Clinical Trial Update: A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating OL-CD19-GDT for relapsed/refractory autoimmune diseases, including systemic sclerosis and Primary Sjögren's syndrome, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome
• Systemic Sclerosis

Drugs mentioned

• OL-CD19-GDT

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Systemic Sclerosis (SSc), Primary Sjogren's Syndrome | Phase 1 | Status: RECRUITING